The olmesartan medoxomil market is witnessing consistent expansion owing to the rising prevalence of hypertension and cardiovascular diseases worldwide. Olmesartan medoxomil, an angiotensin II receptor blocker (ARB), is widely prescribed for the treatment of high blood pressure and related cardiovascular complications. Increasing awareness regarding early diagnosis and long-term...